Marissa Romano
Surgical · Smithtown, NYNPI 1487133575
Payments from drug & device makers
Across 64 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$239
- Collegium Pharmaceutical, Inc.$226
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$92
- Amgen$86
- Forte Bio-pharma LLC$70
- Redhill Biopharma Inc.$48
- plus $305 from 12 others
What the payments were for
- Food & beverage$1,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $239 |
| Collegium Pharmaceutical, Inc. | 21 | $226 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Amgen(2 entities) | 4 | $86 |
| Forte Bio-pharma LLC | 3 | $70 |
| Redhill Biopharma Inc. | 2 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $35 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Relievant Medsystems, Inc. | 1 | $28 |
| Nevro Corp. | 1 | $25 |
| MML US, Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $21 |
| Gamida Cell Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $12 |
How this compares
$1,067 in reported general payments places this provider in the 75th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide | 21 | $4,128 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $2,400 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $1,984 |
| Insulin Aspart FlexpenInsulin Aspart | 21 | $794 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $579 |
| CeftriaxoneCeftriaxone Sodium | 15 | $569 |
| Albuterol Sulfate | 20 | $540 |
| Atorvastatin Calcium | 17 | $278 |
| Baclofen | 21 | $262 |
| Levothyroxine Sodium | 15 | $172 |
| Furosemide | 18 | $127 |
| Gabapentin | 15 | $109 |
Paid to pharmacies, not to this prescriber.
Other surgical in Smithtown
- Kirby TurnerSmithtown$18K
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.